![Richard Bryce](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Bryce
Profile
Richard Paul Bryce is currently a Member of the American Society of Clinical Oncology, Inc., the Royal College of Physicians, the American Association for Cancer Research, the American Society of Hematology, the European Society for Medical Oncology, and the Royal College of General Practitioners.
He is also the Chief Medical Officer at enGene, Inc. starting in 2023.
In his former positions, Dr. Bryce served as the Senior Director-Clinical Science at Onyx Pharmaceuticals, Inc. from 2008 to 2012.
He was also the Director-Medical Affairs & Oncology at ICON plc from 2007 to 2008, and the Senior Director-Medical Affairs & Oncology at ICON Clinical Research, Inc. during the same period.
From 2012 to 2021, he held the position of Chief Medical & Scientific Officer at Puma Biotechnology, Inc. Additionally, he served as the President & Executive VP-Medical Affairs at Ergomed Plc from 2005 to 2007.
He was the Chief Medical Officer at Rain Oncology, Inc. from 2021 to 2023, and the Chief Medical Officer at enGene Holdings, Inc. from 2023 to 2024.
Dr. Bryce obtained his undergraduate and doctorate degrees from The University of Edinburgh in 1981.
Richard Bryce active positions
| Companies | Position | Start |
|---|---|---|
Royal College of General Practitioners
 Royal College of General Practitioners College/University | Corporate Officer/Principal | - |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Corporate Officer/Principal | - |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Corporate Officer/Principal | - |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Corporate Officer/Principal | - |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Chief Tech/Sci/R&D Officer | 31/08/2023 |
Former positions of Richard Bryce
| Companies | Position | End |
|---|---|---|
| ENGENE HOLDINGS INC. | Chief Tech/Sci/R&D Officer | 18/07/2024 |
| RAIN ONCOLOGY INC. | Chief Tech/Sci/R&D Officer | 29/05/2023 |
| ░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Richard Bryce
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in developing innovative therapies that target the molecular mechanisms that cause cancer | Health Technology |
ICON plc
 ICON plc Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services | Commercial Services |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Health Technology |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ICON Clinical Research, Inc.
 ICON Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and consulting services | Commercial Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Health Services |
Royal College of General Practitioners
Royal College of General Practitioners College/University | |
Puma Biotechnology, Inc.
 Puma Biotechnology, Inc. Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | |
Ergomed Plc
 Ergomed Plc Engages in research and development of drugs for oncology & rare diseases | |
Rain Oncology, Inc.
 Rain Oncology, Inc. Operates as a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients | |
enGene Holdings, Inc.
 enGene Holdings, Inc. Operates as a clinical-stage biotechnology company that develops non-viral gene therapies |
- Stock Market
- Insiders
- Richard Bryce
